ArticlePDF Available

Does four weeks of TENS and/or isometric exercise produce cumulative reduction of osteoarthritic knee pain?

Authors:

Abstract and Figures

To evaluate the cumulative effect of repeated transcutaneous electrical nerve stimulation (TENS) on chronic osteoarthritic (OA) knee pain over a four-week treatment period, comparing it to that of placebo stimulation and exercise training given alone or in combination with TENS. Sixty-two patients, aged 50-75, were stratified according to age, gender and body mass ratio before being randomly assigned to four groups. Patients received either (1) 60 minutes of TENS, (2) 60 minutes of placebo stimulation, (3) isometric exercise training, or (4) TENS and exercise (TENS & Ex) five days a week for four weeks. Visual analogue scale (VAS) was used to measure knee pain intensity before and after each treatment session over a four-week period, and at the four-week follow-up session. Repeated measures ANOVA showed a significant cumulative reduction in the VAS scores across the four treatment sessions (session 1, 10, 20 and the follow-up) in the TENS group (45.9% by session 20, p < 0.001) and the placebo group (43.3% by session 20, p = 0.034). However, linear regression of the daily recordings of the VAS indicated that the slope in the TENS group (slope = -2.415, r = 0.943) was similar to the exercise group (slope = -2.625, r = 0.935), which were steeper than the other two groups. Note that the reduction of OA knee pain was maintained in the TENS group and the TENS & Ex group at the four-week follow-up session, but not in the other two groups. The four treatment protocols did not show significant between-group difference over the study period. It was interesting to note that isometric exercise training of the quadriceps alone also reduced knee pain towards the end of the treatment period.
Content may be subject to copyright.
Clinical Rehabilitation 2002; 1 6: 749–760
© Arnold 2002 10.1191/0269215502cr549oa
Address for correspondence: Professor Christina WY Hui-
Chan, Department of Rehabilitation Sciences, The Hong
Kong Polytechnic University, Hung Hom, Kowloon, Hong
Kong. e-mail: rschris@polyu.edu.hk
Does four weeks of TENS and/or isometric
exercise produce cumulative reduction of
osteoarthritic knee pain?
Gladys LY Cheing, Christina WY Hui-Chan Department of Rehabilitation Sciences, The Hong Kong Polytechnic
University, Hung Hom, Kowloon and KM Chan Department of Orthopaedics & Traumatology, The Chinese University of
Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
Received 27th December 2001; returned for revisions 15th April 2002; revised manuscript accepted 26th May 2002.
Objective: To evaluate the cumulative effect of repeated transcutaneous
electrical nerve stimulation (TENS) on chronic osteoarthritic (OA) knee pain
over a four-week treatment period, comparing it to that of placebo stimulation
and exercise training given alone or in combination with TENS.
Design: Sixty-two patients, aged 50–75, were stratied according to age,
gender and body mass ratio before being randomly assigned to four groups.
Interventions: Patients received either (1) 60 minutes of TENS, (2) 60 minutes
of placebo stimulation, (3) isometric exercise training, or (4) TENS and
exercise (TENS & Ex) ve days a week for four weeks.
Main outcome measures: Visual analogue scale (VAS) was used to measure
knee pain intensity before and after each treatment session over a four-week
period, and at the four-week follow-up session.
Results: Repeated measures ANOVA showed a signicant cumulative reduc-
tion in the VAS scores across the four treatment sessions (session 1, 10, 20
and the follow-up) in the TENS group (45.9% by session 20, p < 0.001) and
the placebo group (43.3% by session 20, p = 0.034). However, linear regres-
sion of the daily recordings of the VAS indicated that the slope in the TENS
group (slope = –2.415, r = 0.943) was similar to the exercise group (slope =
–2.625, r = 0.935), which were steeper than the other two groups. Note that
the reduction of OA knee pain was maintained in the TENS group and the
TENS & Ex group at the four-week follow-up session, but not in the other
two groups.
Conclusions: The four treatment protocols did not show signicant between-
group difference over the study period. It was interesting to note that
isometric exercise training of the quadriceps alone also reduced knee pain
towards the end of the treatment period.
750 GLY Cheing et al.
have been a confounding factor.
5
In addition, the
age of the subjects, the intensity and duration of
the stimulation were not controlled.
9
It was proposed that repeated applications of
TENS could serve as a form of afferent condi-
tioning that may produce plastic changes in the
central nervous system over time.
10
Cumulative
antinociceptive effects of TENS on the exion
reex and experimental pain were reported rst
in normal subjects,
11
then in patients who suffer
from chronic clinical pain. Cheing and Hui-
Chan
12
found that repeated applications of 60
minutes of conventional TENS in patients who
suffered from chronic low back pain produced a
cumulative analgesic effect over a two-week
period. There was a 48.8% reduction in subjec-
tive pain sensation by the end of the two-week
treatment period (p < 0.01). However, it could be
argued that low back pain involves the axial
joints and is usually caused by mechanical disor-
ders, whereas OA knee pain occurs in a more
peripheral joint and is usually the result of degen-
erative changes. Therefore, the present study set
out to investigate whether TENS produces cumu-
lative antinociceptive effects in chronic
osteoarthritic knee pain.
Knee pain could reduce the exercise tolerance
of people who have OA knee pain. The strength
of the knee muscles of people with OA knee is
usually weaker than that in normal subjects. Our
previous study found that the isometric peak
torque of the quadriceps in the affected leg of the
patients with OA was reduced by about 26%
when compared with that in normal subjects.
13
Muscle weakness of the quadriceps may in turn
interfere with the normal mechanics around the
knee joint, thus increasing knee pain. A vicious
cycle could therefore be formed. Exercise is
therefore usually advocated for them.
Strengthening exercise to the quadriceps can
improve the stability of the knee joint.
14
Stronger
knee muscles could theoretically provide better
protection of the knee joint by reducing the
excessive stress and strain on the lax joint cap-
sule where the nociceptors are located, to reduce
knee pain during movement. Indeed, Fisher et
al.
15
demonstrated that quadriceps exercise train-
ing improved muscle strength, which was associ-
ated with a 40% reduction in OA knee pain. Our
previous study
16
showed that a four-week iso-
Introduction
Osteoathritis (OA) is a highly prevalent condi-
tion and one of its major symptoms is pain. In
the United States, it was the leading cause of dis-
ability, with the direct and indirect cost of arthri-
tis estimated to be $68.4 billion in 1992.
1
It has
been projected that 59.4 million people in the
United States, or 18.2% of the population, will
suffer from OA by 2020.
2
Transcutaneous electrical nerve stimulation
(TENS) is a common treatment modality for
musculoskeletal pain,
3
and has been demon-
strated to be effective for managing OA knee
pain.
4–9
Briey, TENS but not placebo stimula-
tion, was found to produce a signicant reduction
in subjective pain and in medication scores.
4
Smith et al.
5
reported that the percentage of
respondents experiencing pain relief was sub-
stantially greater in the TENS group (66.7%)
than the placebo group (26.7%), although this
difference was not signicant due to a lack of sta-
tistical power. The percentage of respondents
remained higher in the TENS group at the four-
week follow-up session. Another study showed
that TENS produced a signicantly longer pain
relief period than placebo stimulation.
6
Other
studies also supported the effectiveness of TENS
in managing OA knee pain,
7,8
but most studies
recorded treatment outcomes only at the end of
a treatment period. None of them documented
the time course of possible cumulative analgesic
effects of TENS during the specic treatment
period. Furthermore, previous studies did not
document the duration and amount of analgesic
effect that could be carried over to post-treat-
ment period by repeated applications of TENS.
Such information is essential in determining the
optimal treatment outcome of a given interven-
tion. Furthermore, there were certain method-
ological problems in these studies. For example,
the stimulation was applied by patients at home,
hence the location of electrodes and the treat-
ment duration might not have been controlled
properly.
4
Moreover, when using a cross-over
design, patients could not have been possibly
blinded when switching from TENS to placebo
stimulation, because of a lack of sensation during
placebo stimulation.
4
Also, patients were allowed
to take NSAID during the study, which might
TENS for OA knee pain 751
dominance were recorded. The subjects were
required to sign a consent form and were advised
to keep their activity level and medication
unchanged throughout the study period. They
were randomly allocated to one of the four
groups, receiving the assigned treatment ve days
a week for four weeks (i.e. a total of 5 ´ 4 = 20
sessions). There was a follow-up assessment four
weeks after the termination of treatment.
Treatment procedures
Group 1: TENS
Subjects received daily conventional TENS to
the affected knee for 60 minutes. A dual-channel
portable TENS unit (Staodyn MAXIMA III;
Staodyn Inc., Longmont Co, USA) was used in
this study. Stimulation was given in continuous
trains of 140 µs square pulses at 80 Hz. Four sur-
face electrodes, 4 ´ 4 cm each, were placed on the
following ve acupuncture points: spleen 9, stom-
ach 35, extra 31, 32 and gallbladder 34 (one elec-
trode pad covering both extra 32 and stomach
35).
5,18,19
As noted by previous investigators, the
local tender points coincided with the acupunc-
ture points in most cases.
20
The intensity of TENS
was adjusted to produce a tingling sensation that
was approximately 3–4 times the subject’s sen-
sory threshold. Each subject received the treat-
ment around the same time of the day
throughout the treatment period, to avoid the
uctuation of pain intensity during the day. In
order to blind the subjects from the placebo
effect, all subjects were told that they might or
might not feel the stimulation.
Group 2: Placebo stimulation
Subjects received placebo stimulation at the
same sites for the same duration and period as
the TENS group, except that placebo units were
used for the placebo group. These units were
identical to the real TENS units, and the indica-
tor lamp was lit up when the unit was switched
on. However, the internal circuit had been dis-
connected by the manufacturer (Staodyn Inc.) for
the purpose of our study.
Group 3: Exercise
The Cybex II+ isokinetic dynamometer
(Cybex, Division of Lumex, Inc., New York,
USA) used in the present study was calibrated
metric exercise training of knee muscles pro-
duced a 20.9% gain (p < 0.05 in three selected
knee positions) in the isometric extensor peak
torque, and the addition of TENS to the exercise
training generated a 26.6% gain (p < 0.05 in three
selected knee positions) in the extensor’s peak
torque. Would such an improvement in muscle
strength be associated with any pain reduction?
More importantly, would the addition of TENS
to exercise training produce a greater pain reduc-
tion than TENS or exercise alone?
Therefore, the objectives of the present exper-
iment were twofold:
1) To compare the time course and the effec-
tiveness of a single session of the following
four treatment protocols on the reduction of
OA knee pain intensity: (a) TENS for 60
minutes, (b) placebo stimulation for 60 min-
utes, (c) isometric exercise training for 30
minutes, (d) TENS for 60 minutes and iso-
metric exercise training for 30 minutes
2) To examine the possible cumulative effect of
repeated daily application of the four treat-
ment protocols on OA knee pain over a four-
week period.
Methods
Sixty-six patients with OA knee, aged 50–75, par-
ticipated in the study; 56.0% of the patients had
bilateral knee OA. For patients with bilateral
knee OA, data obtained from the more affected
knee were identied as the affected side. Subjects
were diagnosed and referred by an orthopaedic
surgeon from the Prince of Wales Hospital in
Hong Kong, based on both clinical and radi-
ographic ndings. The inclusion criterion was
grade II (or above) OA changes according to
Kellgren and Lawrence.
17
Eligible subjects had
had OA for more than six months, been stable
on their medication for three weeks before enter-
ing the study, and received no paramedical treat-
ment within the previous two weeks before the
experiment. The exclusion criteria were: prior
knee surgery, prior experience with the use of
TENS and/or having received a steroid injection
within the previous three weeks.
All subjects were able to walk on their own for
10 minutes. Their age, body mass index and leg
752 GLY Cheing et al.
Recording
Arthropometric data such as subjects’ body
weight (kg) and height (m) were collected using
standard clinic scales. The body mass index
(BMI) (kg/m
2
) was calculated by dividing the
body weight by the square of body height. All
subjects were asked to provide information on
their medical history, use of medications, recent
injuries, activity level and history of knee pain.
A visual analogue scale (VAS) was used to
measure the intensity of subjective pain sensa-
tion. The VAS consisted of a 10-cm horizontal
line, anchored with ‘no pain’ at the left end (i.e.
threshold intensity), and ‘pain as bad as it could
be’ at the right (i.e. maximally tolerable inten-
sity). The VAS scores were recorded daily from
session 1 to session 20 and in the follow-up ses-
sion. Subjects were requested to move a mechan-
ical curser along the horizontal line up to a point
that represented their present intensity of knee
pain. After each VAS estimate, the subject was
requested to return the mechanical cursor back
to the left end of the scale. A build-in variable
resistor was attached to the VAS. Any movement
of the cursor generated a voltage output, which
was then fed into a computer to produce a digi-
tal output. In each session, the VAS score was
measured before and 20 minutes after treatment
for all groups. The VAS scores were also mea-
sured at 20, 40 and 60 minutes during stimulation
for groups 1, 2 and 4. Therefore, a total of ve
VAS scores were collected from these three
groups. Only two VAS scores were recorded for
group 3 (before and after the exercise), because
no stimulation was applied to this group.
Statistical analysis
Repeated measures ANOVA using the SPSS
statistics package (version 10.0) was used to
analyse the VAS scores recorded in session 1,
session 10, session 20 and the follow-up session.
The between-subject factor was treatment
‘groups (group 1 to group 4). The within-subject
factor was ‘time’ (before and after stimulation)
and ‘sessions’. To examine the cumulative effects
of each treatment protocol, the pre-treatment
VAS scores of session 10, session 20 and the fol-
low-up session were normalized with respect to
those recorded in session 1. Signicant results
were then analysed by post-hoc tests (LSD – least
monthly by the dealer during the study period.
Subjects received isometric exercise training for
about 20 minutes on each workday for four
weeks. Isometric contraction referred to a negli-
gible movement of the relevant joint. Patients
who participated in the pilot study indicated that
isometric contractions elicited less pain than iso-
tonic or isokinetic exercises. The subjects were
seated with their hip exed at 80° and their back
supported by a backrest. The axis of the
dynamometer arm was aligned with that of the
tested knee. One strap each was used to stabilize
the thigh and the lower leg.
Training was carried out only for the involved
leg (or the more involved leg in cases of bilateral
involvements), and the goal was to strengthen
mainly the knee extensors (quadriceps) with less
focus on the knee exors (hamstrings). The treat-
ment protocol consisted of 10 isokinetic warm-up
knee extension exercises, starting from 90° of
knee exion through the available pain-free
range, at a speed of 180°/s. Three submaximal
isometric quadriceps contractions of increasing
intensity were followed by six maximal 5-second
isometric quadriceps contractions. Most patients
achieved their peak torque within 5 seconds. The
isometric quadriceps contractions were repeated
with the knee exed at 30°, 6 and 90° (E
30°
, E
6
and E
9
) respectively. The isometric peak torque
for the hamstrings was then performed with the
knee exed at 90° (F
90°
). Training was done in the
various knee positions because different muscle
lengths and joint angles are required for various
functional activities such as walking on level
ground, climbing stairs or rising from a chair.
There was a 30-second rest after each contraction
and a 1-minute rest after completing a set of con-
tractions at each knee position. The sequence of
which leg to be tested and the knee positions to
be tested were randomly assigned on session 1
and then maintained for the whole treatment
period. Each training session usually lasted for
about 30 minutes.
Group 4: TENS and exercise (TENS & Ex)
The treatment protocol received by group 1
was combined with that of group 3. Briey, sub-
jects received 60 minutes of TENS followed by
20 minutes of rest, then ended with 30 minutes
of isometric exercise training on the affected leg.
TENS for OA knee pain 753
signicant difference). Finally, linear regression
was used to analyse the changes in the daily
recording of the VAS scores across the 20 treat-
ment sessions. The level of statistical signicance
was set at p < 0.05 for all the tests.
Results
Patient characteristics
Sixty-six patients with OA knee attended the
rst session, and 62 of them completed the four-
week treatment period. Two patients each from
the placebo group and the TENS & Ex group
dropped out of the study due to time conicts and
medical reasons. Table 1 shows the characteris-
tics of patients with OA knee who participated
in the four-week treatment programme. No sig-
nicant differences in the demographic data were
found among the four groups (p > 0.05), except
for the body mass index. The body mass index of
the exercise group was signicantly higher than
that of the TENS & Ex group (p < 0.05). There-
fore, this factor was adjusted in the subsequent
analyses.
Effectiveness of the four treatment protocols
on reducing OA knee pain in session 1
Table 2 shows the VAS scores of the four treat-
ment groups recorded in the various sessions.
The inuence of the four treatment protocols on
the VAS scores recorded in session 1 is shown in
Figure 1a. For between-group comparisons, the
post-treatment VAS scores in session 1 tended to
be lower than those of the pre-treatment with in
each group, except for the exercise group (p =
0.055). The difference in the pre- and post-treat-
ment pain level reached statistical signicance
(p = 0.031). Post-hoc test (LSD) showed that the
difference came from comparing the TENS group
with the exercise group (p = 0.011), and from
comparing the TENS & Ex group with the exer-
cise group (p = 0.008).
The mean VAS scores of the TENS group
dropped gradually over time during session 1,
from a normalized value of 100% before stimu-
lation, to 67.3% (±46.7%) at 60 minutes into
TENS (Figure 1). This score dropped slightly to
64.1% (±40.7%, Table 2) at 20 minutes after
TENS stopped. In contrast, the VAS score of the
placebo group reached 86.3% (±37.5%) at 60
minutes into stimulation (Figure 1), and 84.5%
(±39.6%, Table 2) at 20 minutes after stimula-
tion. For the exercise group, the VAS score
increased to 122.0% (±101%, Table 2) after exer-
cise. The results in the TENS & Ex group were
similar to the TENS group, the VAS score being
decreased to 69.0% (±46.9%, Table 2) at 20 min-
utes after stimulation.
The inuence of the four-week treatment
programme on OA knee pain
The VAS scores recorded in session 10, session
20 and the follow-up session are presented in Fig-
ure 1b–d. Since there was signicant interaction
between ‘groupand ‘session, subsequent analy-
sis was performed separately. For the TENS
group, the pre-stimulation VAS score decreased
to 54.1% of the control value by session 20, and
further to 51.5% in the follow-up session (p =
0.000) (Table 2). For the placebo group, the pre-
stimulation VAS score decreased to 56.7% by
session 20. However, it increased to 67.9% in the
follow-up session (p = 0.034). For the exercise
group, the pre-treatment VAS score was reduced
to 70.7% by session 20 and returned to 93.2% in
Table 1 Patient characteristics
a
Group TENS Placebo Exercise TENS & Ex p-value
n 16 16 15 15
Age 65.3 ± 8.3 64.1 ± 6.1 60.9 ± 7.3 64.3 ± 9.2 0.446
Height (cm) 151.9 ± 7.3 151.8 ± 6.8 155.2 ± 6.9 155.7 ± 6.6 0.243
Weight (kg) 62.6 ± 13.4 66.0 ± 7.7 71.5 ± 12.1 61.7 ± 8.7 0.059
Body mass index (kg/m
2
) 26.8 ± 4.0 28.8 ± 3.7 29.6 ± 4.3 25.5 ± 3.1 0.016*
Gender (female %) 87.5 93.8 86.7 73.3 0.434
*As the body mass index (BMI) was signicantly different between groups (p < 0.05), BMI was adjusted in subsequent
analyses.
754 GLY Cheing et al.
steeper than that of the placebo group, but the
between-group difference was just short of sta-
tistical signicance (p = 0.078).
From session 20 to the follow-up session, none
of the patients received any treatment. Interest-
ingly, the VAS scores were slightly reduced in the
TENS group (by 2.6%) and the TENS & Ex
group (by 7.6%). In contrast, the knee pain
rebounded by 11.2% in the placebo group and by
22.5% in the exercise group.
Discussion
Time course of the analgesic effect of 60
minutes of TENS or placebo stimulation on
OA knee pain
In session 1, TENS analgesia was found to be
developed gradually. These effects peaked at the
end of the stimulation period, and outlasted the
treatment. Such a gradual onset and offset of
TENS analgesia was also demonstrated in people
suffering from chronic low back pain.
21
It is inter-
esting to note that the progressive and prolonged
time course of TENS analgesia is similar to that
produced by endogenous opioids.
22,23
In fact,
acupuncture-like TENS and conventional TENS
the follow-up session (p = 0.407). For the TENS
& Ex group, the pre-treatment VAS score
decreased to 70.6% by session 20 and further to
63.0% in the follow-up session (p = 0.074).
Figure 2 shows the regression lines of the daily
recording of the pre-stimulation VAS scores over
the 20 sessions of treatment. Note that the results
of the follow-up session were not included. The
mean VAS scores in all groups decreased almost
linearly across sessions (all p = 0.000). Using
regression analysis, the slope of the regression
lines for each of the four groups was signicantly
different (p = 0.000). The slope of the regression
line for the TENS group (slope = –2.415, r =
0.943; Figure 2a) and the exercise group (slope =
–2.625, r = 0.935; Figure 2c) was similar (p =
0.565), and were steeper than the other two
groups. However, the pre-stimulation VAS
scores for the exercise group increased by about
27.6% from session 1 to session 3, then decreased
from session 4 onward (Figure 2c). From session
6 to session 20, the knee pain in this group
dropped below the baseline value. The slope of
the placebo group (slope = 1.850, r = 0.878; Fig-
ure 2B) was steeper than the TENS & Ex group
(slope = –1.176, r = 0.809; Figure 2d) (p = 0.037).
The regression line of the TENS group was
Table 2 Summary of the intensity of pain as measured by VAS scores across sessions
Group
a
Session TENS Placebo Exercise TENS & Ex
1 Before 100.0 ± 0 100.0 ± 0 100.0 ± 0 100.0 ± 0
After 64.1 ± 40.7 84.5 ± 39.6 122.0 ± 101 69.0 ± 46.9
Difference
b
35.9 ± 40.7 15.5 ± 39.6 –21.6 ± 101 31.0 ± 46.9
10 Before 68.4 ± 36.1 69.6 ± 42.9 96.4 ± 112 76.0 ± 61.6
After 60.5 ± 35.0 72.2 ± 70.7 87.3 ± 86.0 67.8 ± 51.7
Difference
b
7.9 ± 16.8 –2.7 ± 33.4 9.1 ± 40.7 8.2 ± 18.0
20 Before 54.1 ± 34.3 56.7 ± 36.3 70.7 ± 59.7 70.6 ± 72.7
After 42.2 ± 27.0 50.4 ± 42.4 63.2 ± 64.0 55.6 ± 50.6
Difference
b
11.9 ± 16.1 6.2 ± 25.4 7.6 ± 48.3 15.0 ± 27.7
Follow-up Before 51.5 ± 32.9 67.9 ± 78.6 93.2 ± 111 63.0 ± 55.8
After 43.7 ± 30.3 48.6 ± 42.2 95.2 ± 118 61.1 ± 57.9
Difference
b
7.8 ± 10.6 19.3 ± 2.9 –42.0 ± 20.1 1.9 ± 10.2
p-value ‘session’
c
p = 0.000 p = 0.034 p = 0.407 p = 0.074
a
’BMI’ was not a signicant covariate (p = 0.244). Unadjusted means and standard deviations are therefore presented.
Values are mean ± SD.
b
Difference = before after.
c
Signicant interaction occurred between ‘group’ and ‘session’. Hence, subsequent analysis was carried out separately
for each group, and each session.
TENS for OA knee pain 755
Figure 1 The inuence of the four treatment protocols on the VAS scores in (a) session 1, (b) session 10, (c) session 20 and (d) the follow-up
session. Each data point represents the group mean of the VAS scores normalized with respect to the control value. In session 1, the post-treatment
VAS scores for each group tended to be lower than the pre-treatment scores except for the exercise group (p = 0.055). The change in the pre- and
post-treatment pain scores reached signicant between-group difference (p = 0.031). By session 20, the TENS group tended to show the lowest VAS
score among the four groups.
(a) Session 1 (b) Session 10
(c) Session 20 (d) Follow-up
756 GLY Cheing et al.
Figure 2 The regression lines of the daily recording of the pre-stimulation VAS scores over the 20 treatment sessions. Regression analysis showed
that the slope of the regression lines of each of the four groups was signicantly different (p = 0.000). The slope of the regression line for (a) the
TENS group (slope = –2.415, r = 0.943) and (c) the exercise group (slope = –2.625, r = 0.935) was similar (p = 0.565), and was steeper than the other
two groups. The slope of (b) the placebo group (slope = –1.850, r = 0.878) was steeper than that of (d) the TENS & Ex group (slope = –1.176,
r = 0.809) (p = 0.037).
(a) TENS group (b) Placebo group
(c) Exercise group
(d) TENS & Ex group
TENS for OA knee pain 757
has been shown to increase the release of
endogenous opioids, more specically Met-
enkephalin-Arg-Phe and dynorphin A respec-
tively in the cerebrospinal uid (CSF) of human
subjects.
24
The gradual onset of TENS analgesia
could thus be explained by the time lag observed
in the release of the endogenous opioids. The
gradual offset could be due to the well-known
prolonged effects of these opioid substances
before decaying. Moreover, Dubuisson
25
sug-
gested that the gradual offset of dorsal column
analgesia may be due to the prolonged after-dis-
charges in the cells of the supercial dorsal horn
cells.
Romita and colleagues
10
indicated that intense
peripheral electrical stimulation produced persis-
tent inhibition on the withdrawal reex in rats,
which lasted for more than an hour after the stim-
ulation. However, these investigators applied
high-intensity electrical stimulation (20 times
the sensory threshold) for 20 minutes, which
recruited probably Ad bres in rats. In the pre-
sent study, we applied lower intensity (3–4 times
the sensory threshold) but more prolonged stim-
ulation to human subjects (see also ref. 26). Nev-
ertheless, both types of stimulation patterns
appeared to produce a gradual onset and pro-
longed offset of stimulation-produced analgesia.
The inuence of the four-week treatment
programme on pain intensity
The linear regression lines of the pre-stimula-
tion VAS scores were plotted against treatment
sessions. There were signicant changes in the
VAS scores with in each of the four groups (all
p = 0.000). However, each group performed dif-
ferently between session 20 and the follow-up
session. Specically, the VAS scores were main-
tained in the TENS group and the TENS & Ex
group, but signicantly increased in the placebo
group and the exercise group. This indicated that
the carryover effect of real TENS was longer
than that of the placebo stimulation, or exercise
alone.
Our previous studies demonstrated that two
weeks of daily application of TENS produced
cumulative inhibition on experimental pain in the
normal subjects (p < 0.01),
27
as well as on chronic
low back pain in the patients (p < 0.01).
12
In both
studies, the antinociceptive effect of TENS was
signicantly greater than that of placebo stimu-
lation (all p < 0.05). Zizic and collaborators later
examined the effectiveness of repeated electrical
stimulation on knee pain.
28
They showed that
repeated applications of pulsed electrical stimu-
lation, 6–10 hours/day for four weeks, produced
improvements in knee pain, knee exion and
knee function, and reduced the duration of morn-
ing stiffness for patients with OA knee. There
was a 31.3% pain reduction as measured by VAS
in the treatment group, but only 19.01% for the
placebo group. The present study found a 48.5%
reduction in the TENS group and 43.3% in the
placebo group after four weeks of treatment.
Even though we used only 60 minutes of TENS,
compared with 6–10 hours/day in Zizic’s study,
28
we found a greater analgesic effect but also a
greater placebo effect.
Why did we nd a greater placebo effect as
compared with that of our previous studies on
experimental pain
11
or low back pain;
12
or of
Zizic and colleagues’ study
28
on OA knee pain?
Placebo effect
It was suggested that various factors such as
age, diagnosis, study design, therapist and patient
relationship or cultural differences could con-
tribute to the extent of placebo response. The
placebo effect in this study seems to be stronger
than that reported in our previous studies, which
used a similar treatment protocol and study
design to examine experimental pain in young
normal subjects or chronic low back pain patients
in the patients in Canada.
11,12
Clinical pain could
be more susceptible to placebo effect than
experimental pain.
29
Alternatively, the stronger
Clinical messages
A single treatment session of TENS or
TENS & Ex produced signicantly greater
pain reduction than exercise alone.
Over the four-week treatment period, vari-
ous degree of pain reduction was found in
different groups, but the four treatment pro-
tocols did not show signicant between-
group difference at the end of the study
period.
758 GLY Cheing et al.
the situation. In a companion study, we found
that a four-week exercise programme produced a
signicant increase in isometric peak torque of
knee extensor (an overall of 20.9% gain in the
exercise group; 26.6% gain in the TENS and
exercise group). Now, signicant gain in knee
muscle strength could improve the stability of the
knee joint.
14
With less stress and strain on the
joint capsule where the nociceptors are located,
less pain could be triggered by movement. The
shock-absorbing potential of the muscles around
the knee joint could also be increased. Therefore,
although the introduction of a new exercise
regime may initially increase the knee pain, a sus-
tained exercise training protocol can reduce knee
pain. In addition to the reduction of knee pain,
appropriate exercise could help to maintain bone
mineral content and ultrastructure, therefore pre-
serving the compliance of the subchondral bone.
From session 20 to the follow-up, there
appeared to be some detraining effect and the
strength of the quadriceps could be reduced. The
exercise group reported an increase in knee
pain by 22.5%. Note that such a return of knee
pain was not found in the TENS & Ex
group. Therefore, the addition of TENS to exer-
cise training could alleviate an increase in knee
pain at the beginning of exercise training.
Also, a four-week TENS & Ex treatment tended
to produce a longer carryover effect on pain
relief than exercise alone. It lasted for up to four
weeks after the termination of the treatment
period.
Conclusion
A single treatment session of TENS or TENS &
Ex produced signicantly greater pain reduction
than the exercise group. Over the four-week
treatment period, various degree of pain reduc-
tion was found in the different groups, but the
four treatment protocols did not show signicant
between-group difference at the end of the treat-
ment period, at least with in the patient sample
studied. It was interesting to note that isometric
exercise training temporarily increased knee pain
during the initial 2–3 treatment sessions, but
reduced pain below the baseline value from ses-
sion 4 to session 20. However, the pain reduction
placebo effect may be attributable to cultural fac-
tors.
30,31
For instance, Johnson and Din
31
demon-
strated that the effect of placebo TENS produced
a signicantly greater increase in cold-pain
threshold and a signicantly greater reduction in
pain intensity rating in Asian subjects than in
Caucasian subjects.
Exercise and OA knee pain
The inuence of the isometric exercise training
on knee pain varied during the course of treat-
ment. During the rst three sessions, exercise
training actually increased knee pain by 20%.
From session 4 to session 20, exercise reduced
knee pain to 70.7%. From session 20 to the fol-
low-up session, the cessation of exercise training
resulted in a return of knee pain to 93.2% of the
baseline value.
During the rst three sessions, quadriceps con-
tractions could have increased the compression
force on the knee joints thereby increasing knee
pain. The new exercise regime might have pro-
duced excessive stretch on the joint capsule or
periarticular structures where the nociceptors are
located.
32
There are substance P bres around the
knee joint including fat pads, periosteum and
subchondral bone.
33
Mechanical or chemical exci-
tation of the periarticular nociceptors located in
various soft tissues could explain the increase in
osteoarthritic knee pain at this stage. Note that
such an increase in pain during the rst few ses-
sions were not reported by subjects in the TENS
& Ex group.
From session 4 onwards, most patients
appeared to have adapted to the exercise train-
ing, which could explain the gradual reduction of
pain observed. The quadriceps muscles are
important in supporting a exed knee, and play
an important role in the stability of the knee
joint. To compensate for quadriceps deciency,
patients with OA knee tend to avoid exing their
knees when they walk.
34
Unfortunately, walking
with a rigid limb will reduce the shock-absorbing
effect of the knee joint. The impact of the body
weight will thus be transmitted directly from the
femur to the tibia with out any muscular cush-
ioning effect. This may further irritate the noci-
ceptors around the knee joint and increase knee
pain.
However, strengthening exercise can reverse
TENS for OA knee pain 759
study of Pain, 1996 Aug 17–22. Vancouver. Seattle
(WA): IASP Press; 1996: 85.
13 Cheing GLY, Hui-Chan CWY. The motor
dysfunction of patients with osteoarthritic knee in a
Chinese population.
Arthritis Care Res 2001; 45:
62–68.
14 Gerber LH. Exercise and arthritis. Bull Rheum Dis
1990; 39: 1–9.
15 Fisher NM, Pendergast DR, Gresham GE, Calkins
E. Muscle rehabilitation: its effect on muscular and
functional performance of patients with knee
osteoarthritis. Arch Phys Med Rehabil 1991; 72:
367–74.
16 Cheing GLY, Hui-Chan CWY, Chan KM. The
addition of exercise training to TENS produced
better treatment outcomes for clients with
osteoarthritic knee pain. In: Abstracts of the 9th
World Congress: The Pain Clinic, 2000 July, San
Francisco, CA, 2000: 47.
17 Kellgren JH, Lawrence JS. Radiological assessment
of osteoarthosis. Ann Rheum Dis 1957; 16:
494–502.
18 The Academy of Traditional Chinese Medicine. An
outline of Chinese acupuncture. Peking: Foreign
Language Press, 1975.
19 Takeda W, Wessel J. Acupuncture for the treatment
of pain of osteoarthritic knees. Arthritis Care Res
1994; 7: 11822.
20 Andersson SA, Holmgren E. On acupuncture
analgesia and the mechanism of pain. Am J Chin
Med 1975; 3: 311–34.
21 Cheing G, Hui-Chan CW. Non-parallel
antinociceptive effects of transcutaneous electrical
nerve stimulation on chronic clinical pain and acute
experimental pain. Arch Phys Med Rehabil 1999; 80:
305–12.
22 Spampinato S, Candeletti S. Characterization of
dynorphin A-induced antinociception at spinal level.
Eur J Pharmacol 1985; 110: 2130.
23 Wang JQ, Mao L, Han JS. Comparison of the
antinociceptive effects induced by
electroacupuncture and transcutaneous electrical
nerve stimulation in the rat. Int J Neurosci 1992; 65:
117–29.
24 Han JS, Chen XH, Sun SL et al. Effect of low- and
high-frequency TENS on Met-enkephalin-Arg-Phe
and dynorphin A immunoreactivity in human
lumbar CSF. Pain 1991; 47: 295–98.
25 Dubuisson D. Effect of dorsal-column stimulation on
gelatinosa and marginal neurons of cat spinal cord. J
Neurosurg 1989; 70: 257–65.
26 Levin MF, Hui-Chan CW. Conventional and
acupuncture-like transcutaneous electrical nerve
stimulation excite similar afferent bers. Arch Phys
Med Rehabil 1993; 74: 54–60.
27 Liu J, Hui-Chan CW. Long-term afferent
conditioning produces cumulative inhibitory
inuence on pain sensation and exion reex. In:
produced by exercise ceased gradually once the
exercise training was terminated.
References
1 Yelin E, Callahan LF. The economic cost and social
and psychological impact of musculoskeletal
conditions. National Arthritis Data Work Groups.
Arthritis Rheum 1995; 38: 135162.
2 CDC. Arthritis prevalence and activity limitations
United States, 1990. MMWR Morb Mortal Wkly
Rep 1994; 43: 433–38.
3 Robinson AJ. Transcutaneous electrical nerve
stimulation for the control of pain in
musculoskeletal disorders. J Orthop Sports Phys
Ther 1996; 24: 208–26.
4 Taylor P, Hallett M, Flaherty L. Treatment of
osteoarthritis of the knee with transcutaneous
electrical nerve stimulation. Pain 1981; 11: 233–40.
5 Smith CR, Lewith GT, Machin D. TNS and
osteo-arthritic pain. Preliminary study to establish a
controlled method of assessing transcutaneous nerve
stimulation as a treatment for the pain caused by
osteo-arthritis of the knee. Physiotherapy 1983; 69:
266–68.
6 Lewis D, Lewis B, Sturrock RD. Transcutaneous
electrical nerve stimulation in osteoarthrosis: a
therapeutic alternative? Ann Rheum Dis 1984; 43:
47–49.
7 Jensen H, Zesler R, Christensen T. Transcutaneous
electrical nerve stimulation (TENS) for painful
osteoarthrosis of the knee. Int J Rehabil Res 1991;
14: 356–58.
8 Fargas-Babjak AM, Pomeranz B, Rooney PJ.
Acupuncture-like stimulation with codetron for
rehabilitation of patients with chronic pain syndrome
and osteoarthritis. Acupunct Electrother Res 1992;
17: 95–105.
9 Lewis B, Lewis D, Cumming G. The comparative
analgesic efcacy of transcutaneous electrical nerve
stimulation. Br J Rheumatol 1994; 33: 455–60.
10 Romita VV, Yashpal K, Hui-Chan CWY, Henry JL.
Intense peripheral electrical stimulation evokes brief
and persistent inhibition of the nociceptive tail with
drawal reex in the rat. Brain Res 1997; 761:
192–202.
11 Liu J, Hui-Chan CW. Do the effects of repetitive
transcutaneous electrical nerve stimulation on
experimental pain cumulate over time? Soc Neurosci
Abstr 1993; 19: 965.
12 Cheing G, Hui-Chan CW. Repeated applications of
transcutaneous electrical nerve stimulation (TENS)
produce cumulative effects on chronic clinical pain
but not acute experimental pain in chronic low back
pain patients. In: Abstracts of the 8th World
Congress on the International Association for the
760 GLY Cheing et al.
analgesic effects of placebo transcutaneous electrical
nerve stimulation on cold-induced pain in healthy
subjects: a preliminary study. Complement Ther Med
1997; 5: 7479.
32 Zimmermann M. Pain mechanisms and mediators in
osteoarthritis. Semin Arthritis Rheum 1989; 18 (4
suppl 2): 22–29.
33 Wojtys EM, Beaman DN, Glover RA, Janda D.
Innervation of the human knee joint by substance-P
bers. Arthroscopy 1990; 6: 254–63.
34 Perry J. Knee abnormal gait. In: Gait analysis:
normal and pathological function. New Jersey: Slack
Incorporated, 1992: 223–44.
Proceedings of the 10th Annual Spinal Cord Injury
Research Symposium, October 1994. Montreal:
Symposium Organizing Committee, 1994: 8.
28 Zizic TM, Hoffman KC, Holt PA et al. The
treatment of osteoarthritis of the knee with pulsed
electrical stimulation. J Rheumatol 1995; 22: 1757–61.
29 Fields HL, Price DD. Towards a neurobiology of
placebo analgesia. In: Harrington A ed. The placebo
effect. Cambridge: Harvard University Press, 1997:
93–116.
30 Yang KS. Chinese personality and its change. In:
Bond MH ed. The psychology of the Chinese people.
New York: Oxford University Press, 1986: 106–70.
31 Johnson M, Din A. Ethnocultural differences in the
... The search strategy was developed in consultation from a research librarian (Supplementary Table 1). We extended searches by examining reference lists of included studies (Balasch-Bernat et al., 2021;Balchin et al., 2020;Cheing et al., 2002;Coombes et al., 2016;Helmark et al., 2010;Hoeger Bement et al., 2014;Joseph et al., 2018;Neelapala et al., 2018;Paungmali et al., 2017;Pazit et al., 2018;Riel et al., 2018;Skoffer et al., 2018;van der Vlist et al., 2020;Yaghoubi et al., 2014;Alsouhibani and Bement, 2022;Sipko et al., 2021;Sitges et al., 2021) and relevant systematic reviews (Rice et al., 2019;Naugle et al., 2012;Vaegter and Jones, 2020;Wewege and Jones, 2021;Bonello et al., 2021;Polaski et al., 2019), and by conducting forward citation tracking of included studies by finding included articles on Google Scholar and searching through the first 100 articles citing that study. ...
... The study selection process is summarised in Fig. 1. Seventeen studies were included in the review (46 study arms with 664 adults) (Balasch-Bernat et al., 2021;Balchin et al., 2020;Cheing et al., 2002;Coombes et al., 2016;Helmark et al., 2010;Hoeger Bement et al., 2014;Joseph et al., 2018;Neelapala et al., 2018;Paungmali et al., 2017;Pazit et al., 2018;Riel et al., 2018;Skoffer et al., 2018;van der Vlist et al., 2020;Yaghoubi et al., 2014;Alsouhibani and Bement, 2022;Sipko et al., 2021;Sitges et al., 2021). There were 293 females (44%) across included studies, however, two studies (Balchin et al., 2020;Sipko et al., 2021) did not report the number of males and females. ...
... One included trial was ongoing (Balchin et al., 2020). We were unable to use arm level data for one study (Cheing et al., 2002) as pain intensity ratings were standardised as 100% at baseline, with all pain ratings reported relative to baseline, and we were unable to obtain raw data following author contact. Characteristics of included studies and intervention details are outlined in Table 1 and Supplementary Table 6, respectively. ...
Article
Background Chronic pain is prevalent amongst society, making it necessary to find strategies to manage chronic pain. Regular exercise is efficacious; however, pain is a barrier to initiating exercise. A single exercise session is also believed to acutely reduce pain, however, the evidence is less robust. Objectives This systematic review and meta-analysis aimed to identify the effect of a single exercise session on pain intensity in adults with chronic pain. Methods We searched eight databases and trial registries to identify randomised controlled trials evaluating the effect of a single exercise session on pain intensity in adults with chronic pain compared to a non-exercise control. Literature screening, data extraction, risk of bias (Cochrane 2.0) and quality assessment (GRADE) were conducted independently and in duplicate. Random-effects meta-analyses were performed using the metafor package in R. Results We included 17 trials (46 study arms with 664 adults [44% female]). There were no significant differences in pain intensity (mean difference on a 0-10 scale) immediately post-exercise −0.02 (95% CI = −0.06, 0.62; I² = 77.1%) or up to 45-minutes post-exercise −0.17 (95% CI = −0.49, 0.16; I² = 34.2%). All trials were at high risk of bias and the overall confidence in these findings was very low. Conclusion A single exercise session did not reduce pain intensity up to 1-hour post-exercise. Notably, increases in pain were not observed either, suggesting that while pain can be a barrier to initiating exercise, clinicians can educate patients on the unlikelihood of exercise acutely increasing pain intensity.
... Physical therapy provides a variety of intervention such as manual therapy techniques, balance, coordination and functional retraining techniques, knee taping techniques etc 8 . Transcutaneous electrical nerve stimulation (TENS) is a common treatment modality for musculoskeletal pain and has been demonstrated to be effective for managing osteoarthritis knee pain 9 . Many researchers have shown the effectiveness of TENS and exercise therapy separately in the management of knee OA. ...
... Corticosteroides: A administração de corticosteroides, como a dexametasona, pode reduzir significativamente a dor e a inflamação, mas com atenção rigorosa aos potenciais efeitos sistêmicos (Jules-Elysee et al., 2011). Journal of Health Review, Curitiba, v. 6, n. 6, p. 31221-31236, nov./dec., 2023 3.7 ESTRATÉGIAS NÃO FARMACOLÓGICAS Crioterapia: A aplicação de frio tem demonstrado ser eficaz na redução da dor e do edema no período pós-operatório de ATQ, principalmente nas primeiras 48 horas após o procedimento(Adie et al., 2012).Eletroterapia: A utilização de TENS tem sido adotada como uma estratégia não invasiva e não farmacológica para a gestão da dor no cenário pós-operatório, proporcionando alívio da dor mediante a modulação do limiar da dor(Cheing et al., 2005).Terapia Manual: Intervenções como a drenagem linfática manual podem atenuar o edema e, por conseguinte, a dor, no pós-operatório, favorecendo a recuperação inicial (Tick et al., 2018). Bloqueio Nervoso: Bloqueios de nervos periféricos, tais como o bloqueio do plexo lombar, têm se mostrado uma alternativa eficaz e segura na gestão da dor pós-ATQ, minimizando a necessidade de analgésicos sistêmicos (Ilfeld et al., 2017). ...
Article
A Artroplastia Total de Quadril (ATQ) representa um marco no tratamento de diversas patologias do quadril, com o objetivo primário de aliviar a dor e restaurar a mobilidade. Este estudo aborda as indicações para ATQ, estratégias de reabilitação e desfechos clínicos, enfatizando a importância da decisão compartilhada e do manejo eficaz da dor. Foi realizada uma revisão integrativa nas bases de dados PubMed, Scopus e Embase, empregando palavras-chave como "Artroplastia Total de Quadril", "Reabilitação", e "Indicações". Os critérios de inclusão se basearam na relevância e atualidade das informações, independentemente do ano de publicação. A osteoartrite surgiu como a indicação predominante para ATQ. Estratégias de reabilitação modernas, incluindo mobilização precoce e fortalecimento muscular, mostraram-se essenciais no processo de recuperação. O controle da dor, através de abordagens farmacológicas e não farmacológicas, foi identificado como um fator crítico para uma reabilitação bem-sucedida. A participação ativa do paciente nas decisões de tratamento foi associada a melhores resultados clínicos e maior satisfação. A ATQ é uma intervenção valiosa para restaurar a qualidade de vida em pacientes com patologias significativas do quadril. A seleção cuidadosa dos pacientes, um programa de reabilitação bem estruturado e um manejo efetivo da dor são fundamentais para o sucesso do tratamento. A tomada de decisões compartilhada é crucial para alinhar as expectativas do paciente com os resultados clínicos.
... Based on high-quality evidence of mid-term and long-term effects, ET is now suggested as the recommended treatment for individuals with knee OA [18]. A variety of transcutaneous electrical nerve stimulation (TENS) applications are used by PTs to manage pain in knee OA patients [19]. TENS can be used in combination with exercise or physical activity to help relieve pain, or it can be used as a separate pain treatment. ...
Article
Full-text available
Background Knee osteoarthritis (OA) is the most common kind of arthritis that occurs due to degeneration of the joint articular cartilage, producing pain, stiffness, and impaired movement. The objective of the study was to evaluate the short-term effectiveness of Kinesio taping (KT) plus conventional physical therapy (CPT) and CPT alone in subjects with knee OA. Materials and methods Forty male subjects were divided into two groups at random using a parallel assignment, double-blinded study design, viz., KT with CPT (transcutaneous electrical nerve stimulation and exercise therapy), and CPT alone for the period of 6 weeks of treatment. At baseline, third, and sixth weeks, the following outcome measures were taken, such as pain intensity (NPRS), knee range of motion (goniometry), Western Ontario and McMaster Osteoarthritis Index (WOMAC), and the Time Up and Go (TUG) test. Statistical analysis To reveal the patient’s demographic profile concerning the outcome parameters, a descriptive statistic was applied. Furthermore, two-way mixed ANOVA and Tukey HSD post hoc tests were used to analyze within and between-group comparisons in SPSS 20.0. Results In both groups, pain and knee flexion were significantly improved during the 6-week period of interventions ( p < 0.05). WOMAC and TUG test scores improved only in the KT plus CPT group. Conclusion KT combined with CPT was found to be more effective than CPT alone in the third and sixth weeks of the treatment. In knee OA, this combination of treatments was found to reduce pain, enhance range of motion, and improve physical functioning.
... However, the intervening spikes in post-intervention VAS scores during the 10 weeks TENS intervention are manifest in the line graph. These findings from the current study tend to agree with the previous studies which reported that TENS application was effective in the management of varying kinds of musculoskeletal and post-surgical pain [1,[22][23][24][25][26][27][28][29][30][31][32][33][34]. ...
Article
Full-text available
Background Studies to determine gender response to transcutaneous electrical nerve stimulation (TENS) application on individuals who presented with post-injection sciatic pain (PISP) following gluteal injection is not common. A total of 40 subjects comprising 20 males and 20 females who were purposively recruited and conveniently assigned to group A (male) and group B (female) completed the study. Acupuncture-like TENS (AL-TENS) was applied on the 20 male and 20 female subjects, 1 h per session, 3 times per week for the 10 weeks the study lasted. Result The pre-intervention baseline scores for the two groups were 8.80 + 1.05 (Female) and 8.60 + 1.27 (Male). The result revealed that after 10 weeks of intervention the VAS scores were 2.60 + 3.28 ( p < 0.001) and 2.40 + 3.28 ( p < 0.001) for the female and male subjects, respectively. The mean comparison of the female mean VAS scores (2.60 + 3.28) and male VAS scores 2.40 + 3.25 after 10 weeks of AL-TENS intervention shows no statistically significant difference ( p > 0.85) in pain intensity (pain perception). Conclusions There was no gender variation in pain perception in subjects with post-injection sciatic pain (PISP) following gluteal muscle injection after 10 weeks of AL-TENS application. Therefore, gender-based variation should not be considered when applying AL-TENS as an instrument of intervention in subjects with PISP. Trial registration PACTR2018050034082
... Only four randomised controlled trials that compared an exercise intervention to placebo were identified; one each 288 in osteoarthritis [69], chronic low back pain [85], chronic patellofemoral pain [80], and fibromyalgia [60]. None 289 of these studies used a placebo exercise training protocol. ...
Article
Full-text available
Background: Pain is the most disabling characteristic of musculoskeletal disorders, and while exercise is promoted as an important treatment modality for chronic musculoskeletal conditions, the relative contribution of the specific effects of exercise training, placebo effects and non-specific effects such as natural history are not clear. The aim of this systematic review and meta-analysis was to determine the relative contribution of these factors to better understand the true effect of exercise training for reducing pain in chronic primary musculoskeletal pain conditions. Design: Systematic review with meta-analysis DATA SOURCES: MEDLINE, CINAHL, SPORTDiscus, EMBASE and CENTRAL from inception to February 2021. Reference lists of prior systematic reviews. Eligibility criteria: Randomised controlled trials of interventions that used exercise training compared to placebo, true control or usual care in adults with chronic primary musculoskeletal pain. The review was registered prospectively with PROSPERO (CRD42019141096). Results: We identified 79 eligible trials for quantitative analysis. Pairwise meta-analysis showed very low-quality evidence (GRADE criteria) that exercise training was not more effective than placebo (g [95% CI]: 0.94 [- 0.17, 2.06], P = 0.098, I2 = 92.4%, studies: n = 4). Exercise training was more effective than true, no intervention controls (g [95% CI]: 1.02 [0.67, 1.36], P < 0.001, I2 = 92.99%, studies: n = 42), usual-care controls (g [95% CI]: 0.65 [0.41, 0.89], P < 0.001, I2 = 84.82%, studies: n = 33), and when all controls combined (g [95% CI]: 0.86 [0.64, 1.07], P < 0.001, I2 = 91.37%, studies: n = 79). Conclusions: There is very low-quality evidence that exercise training is not more effective than non-exercise placebo treatments in chronic pain. Exercise training and the associated clinical encounter are more effective than true control or standard medical care for reductions in pain for adults with chronic musculoskeletal pain, with very low quality of evidence based on GRADE criteria.
Article
This report provides a systematic review of the literature to analyze the effects of transcutaneous electrical nerve stimulation (TENS) on analgesia on sensitization measures, in studies with chronic musculoskeletal pain and in studies with acute experimental pain. The protocol was registered at PROSPERO (CRD42020213473). The authors searched CENTRAL, CINAHL, EMBASE, LILACS via BVS, PEDro, PubMed, Science Direct, Web of Science, Google Scholar, and hand-searched reference lists were also conducted. Among 22,252 manuscripts found, 58 studies were included in the systematic review, and 35 in the meta-analysis. Thirty-four studies assessed pain intensity; 24 studies investigated hyperalgesia; temporal summation was only evaluated in two studies; and conditioned pain modulation was not observed in the included studies. Meta-analyses favored TENS, despite its limitations and heterogeneity. Primary hyperalgesia in studies with musculoskeletal pain presented a high level of evidence, while other outcomes presented moderate evidence in the studies that were included. It is not possible to infer results about both temporal summation and conditioned pain modulation. Moderate evidence suggests that TENS promotes analgesia by reducing both central and peripheral sensitization, as shown by the reduction in primary and secondary hyperalgesia, pain intensity at rest, and during movement in the experimental acute pain and chronic musculoskeletal pain. Overall, both types of studies analyzed in this review presented meta-analyses favorable to the use of TENS (compared to placebo TENS), showing reductions in both primary and secondary hyperalgesia, as well as decreases in pain intensity at rest and in motion. PERSPECTIVE: This article presents data from the literature on the effect of TENS through sensitization assessments in individuals with chronic musculoskeletal pain, or acute experimental pain. These data contribute to knowledge about pain neuroscience research, using TENS technology.
Article
Full-text available
Background: Land-based exercise therapy is recommended in clinical guidelines for hip or knee osteoarthritis. Adjunctive non-pharmacological therapies are commonly used alongside exercise in hip or knee osteoarthritis management, but cumulative evidence for adjuncts to land-based exercise therapy is lacking. Objectives: To evaluate the benefits and harms of adjunctive therapies used in addition to land-based exercise therapy compared with placebo adjunctive therapy added to land-based exercise therapy, or land-based exercise therapy only for people with hip or knee osteoarthritis. Search methods: We searched CENTRAL, MEDLINE, PsycINFO, EMBASE, CINAHL, Physiotherapy Evidence Database (PEDro) and clinical trials registries up to 10 June 2021. Selection criteria: We included randomised controlled trials (RCTs) or quasi-RCTs of people with hip or knee osteoarthritis comparing adjunctive therapies alongside land-based exercise therapy (experimental group) versus placebo adjunctive therapies alongside land-based exercise therapy, or land-based exercise therapy (control groups). Exercise had to be identical in both groups. Major outcomes were pain, physical function, participant-reported global assessment, quality of life (QOL), radiographic joint structural changes, adverse events and withdrawals due to adverse events. We evaluated short-term (6 months), medium-term (6 to 12 months) and long-term (12 months onwards) effects. Data collection and analysis: Two review authors independently assessed study eligibility, extracted data, and assessed risk of bias and certainty of evidence for major outcomes using GRADE. Main results: We included 62 trials (60 RCTs and 2 quasi-RCTs) totalling 6508 participants. One trial included people with hip osteoarthritis, one hip or knee osteoarthritis and 59 included people with knee osteoarthritis only. Thirty-six trials evaluated electrophysical agents, seven manual therapies, four acupuncture or dry needling, or taping, three psychological therapies, dietary interventions or whole body vibration, two spa or peloid therapy and one foot insoles. Twenty-one trials included a placebo adjunctive therapy. We presented the effects stratified by different adjunctive therapies along with the overall results. We judged most trials to be at risk of bias, including 55% at risk of selection bias, 74% at risk of performance bias and 79% at risk of detection bias. Adverse events were reported in eight (13%) trials. Comparing adjunctive therapies plus land-based exercise therapy against placebo therapies plus exercise up to six months (short-term), we found low-certainty evidence for reduced pain and function, which did not meet our prespecified threshold for a clinically important difference. Mean pain intensity was 5.4 in the placebo group on a 0 to 10 numerical pain rating scale (NPRS) (lower scores represent less pain), and 0.77 points lower (0.48 points better to 1.16 points better) in the adjunctive therapy and exercise therapy group; relative improvement 10% (6% to 15% better) (22 studies; 1428 participants). Mean physical function on the Western Ontario and McMaster (WOMAC) 0 to 68 physical function (lower scores represent better function) subscale was 32.5 points in the placebo group and reduced by 5.03 points (2.57 points better to 7.61 points better) in the adjunctive therapy and exercise therapy group; relative improvement 12% (6% better to 18% better) (20 studies; 1361 participants). Moderate-certainty evidence indicates that adjunctive therapies did not improve QOL (SF-36 0 to 100 scale, higher scores represent better QOL). Placebo group mean QOL was 81.8 points, and 0.75 points worse (4.80 points worse to 3.39 points better) in the placebo adjunctive therapy group; relative improvement 1% (7% worse to 5% better) (two trials; 82 participants). Low-certainty evidence (two trials; 340 participants) indicates adjunctive therapies plus exercise may not increase adverse events compared to placebo therapies plus exercise (31% versus 13%; risk ratio (RR) 2.41, 95% confidence interval (CI) 0.27 to 21.90). Participant-reported global assessment was not measured in any studies. Compared with land-based exercise therapy, low-certainty evidence indicates that adjunctive electrophysical agents alongside exercise produced short-term (0 to 6 months) pain reduction of 0.41 points (0.17 points better to 0.63 points better); mean pain in the exercise-only group was 3.8 points and 0.41 points better in the adjunctive therapy plus exercise group (0 to 10 NPRS); relative improvement 7% (3% better to 11% better) (45 studies; 3322 participants). Mean physical function (0 to 68 WOMAC subscale) was 18.2 points in the exercise group and 2.83 points better (1.62 points better to 4.04 points better) in the adjunctive therapy plus exercise group; relative improvement 9% (5% better to 13% better) (45 studies; 3323 participants). These results are not clinically important. Mean QOL in the exercise group was 56.1 points and 1.04 points worse in the adjunctive therapies plus exercise therapy group (1.04 points worse to 3.12 points better); relative improvement 2% (2% worse to 5% better) (11 studies; 1483 participants), indicating no benefit (low-certainty evidence). Moderate-certainty evidence indicates that adjunctive therapies plus exercise probably result in a slight increase in participant-reported global assessment (short-term), with success reported by 45% in the exercise therapy group and 17% more individuals receiving adjunctive therapies and exercise (RR 1.37, 95% CI 1.15 to 1.62) (5 studies; 840 participants). One study (156 participants) showed little difference in radiographic joint structural changes (0.25 mm less, 95% CI -0.32 to -0.18 mm); 12% relative improvement (6% better to 18% better). Low-certainty evidence (8 trials; 1542 participants) indicates that adjunctive therapies plus exercise may not increase adverse events compared with exercise only (8.6% versus 6.5%; RR 1.33, 95% CI 0.78 to 2.27). Authors' conclusions: Moderate- to low-certainty evidence showed no difference in pain, physical function or QOL between adjunctive therapies and placebo adjunctive therapies, or in pain, physical function, QOL or joint structural changes, compared to exercise only. Participant-reported global assessment was not reported for placebo comparisons, but there is probably a slight clinical benefit for adjunctive therapies plus exercise compared with exercise, based on a small number of studies. This may be explained by additional constructs captured in global measures compared with specific measures. Although results indicate no increased adverse events for adjunctive therapies used with exercise, these were poorly reported. Most studies evaluated short-term effects, with limited medium- or long-term evaluation. Due to a preponderance of knee osteoarthritis trials, we urge caution in extrapolating the findings to populations with hip osteoarthritis.
Article
Full-text available
Background and Objectives: Characterising the features of methodologies, clinical attributes and intervention protocols, of studies is valuable to advise directions for research and practice. This article reports the findings of a secondary analysis of the features from studies screened as part of a large systematic review of TENS (the meta-TENS study). Materials and Methods: A descriptive analysis was performed on information associated with methodology, sample populations and intervention protocols from 381 randomised controlled trials (24,532 participants) evaluating TENS delivered at a strong comfortable intensity at the painful site in adults with pain, irrespective of diagnosis. Results: Studies were conducted in 43 countries commonly using parallel group design (n = 334) and one comparator group (n = 231). Mean ± standard deviation (SD) study sample size (64.05 ± 58.29 participants) and TENS group size (27.67 ± 21.90 participants) were small, with only 13 of 381 studies having 100 participants or more in the TENS group. Most TENS interventions were ‘high frequency’ (>10 pps, n = 276) and using 100 Hz (109/353 reports that stated a pulse frequency value). Of 476 comparator groups, 54.2% were active treatments (i.e., analgesic medication(s), exercise, manual therapies and electrophysical agents). Of 202 placebo comparator groups, 155 used a TENS device that did not deliver currents. At least 216 of 383 study groups were able to access other treatments whilst receiving TENS. Only 136 out of 381 reports included a statement about adverse events. Conclusions: Clinical studies on TENS are dominated by small parallel group evaluations of high frequency TENS that are often contaminated by concurrent treatment(s). Study reports tended focus on physiological and clinical implications rather than the veracity of methodology and findings. Previously published criteria for designing and reporting TENS studies were neglected and this should be corrected in future research using insights gleaned from this analysis.
Article
Full-text available
Objective To evaluate the effects of Transcutaneous Electric Nerve Stimulation (TENS) on pain, function, walking ability and stiffness in people with Knee osteoarthritis (KOA). Design Systematic review and meta-analysis of randomized controlled trials. Methods We searched MEDLINE, EMBASE, PubMed, Cochrane Central Register of Controlled Trials, Physiotherapy Evidence Database (PEDro), clinicaltrials.gov and Web of Science (last search November 2021) for randomized controlled trials. The Cochrane Risk of Bias Tool was used for the included studies, and Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) was used to interpret the certainty of results. Standardized Mean Differences (SMDs) and 95% confidence interval (CI) were calculated for meta-analysis. Results Twenty-nine studies were found (1398 people, age range 54-85, 74% are female) and fourteen were included in this review. Intervention duration was divided as short term (immediately after intervention), medium term (<four weeks) and long term (≥ four weeks). Active TENS showed greater improvement in Visual Analogue Scale (VAS) than sham TENS.Combining TENS with other interventions produced superior outcomes compared with other interventions for VAS in all the terms. In the meanwhile, TENS combined with other interventions was superior to other interventions for the pain subgroup of Western Ontario and McMaster Universities Arthritis Index in the medium term and long term. TENS combined with other interventions was superior to other interventions for function in the medium term and long term. Conclusion TENS could significantly relieve pain, decrease dysfunction and improve walking ability in people with KOA, but it is not effective for stiffness.
Article
Objective. The purpose of this study was to determine whether acupuncture was more effective than sham acupuncture in the reduction of pain in persons with osteoarthritis (OA) of the knee. Methods. Forty subjects (20 men, 20 women) with radiographic evidence of OA of the knee were stratified by gender and randomly assigned to either the experimental (real acupuncture) or control (sham acupuncture) groups. Subjects were treated three times per week for 3 weeks and evaluated at three test sessions. Outcome measures were: 1) the Pain Rating Index of the McGill Pain Questionnaire, 2) the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index, and 3) pain threshold at four sites at the knee. Results. The analyses of variance showed that both real and sham acupuncture significantly reduced pain, stiffness, and physical disability in the OA knee, but that there were no significant differences between groups. Conclusions. Acupuncture is not more effective than sham acupuncture in the treatment of OA pain.
Article
With the emphasis placed on placebo-controlled methodology in the testing of novel therapies, it is important that placebo effects are studied in their own right. Placebo effects, which may occur whenever a patient and a physician perceive a treatment as effective, may be susceptible to ethnocultural influences. However, experiments utilizing human subjects rarely take ethnocultural effects into account. This preliminary single-blind study examined the analgesic effects of placebo transcutaneous electrical nerve stimulation (TENS) on cold-induced pain in 24 healthy first-generation UK-born Asian and White Anglo-Saxon subjects. Pain threshold and pain intensity rating measurements were taken during six 10-min experimental cycles (two pre-, two during and two post-treatment) of the cold-induced pain test. A portable TENS unit with no current output was used to administer placebo TENS during the two treatment cycles. Two-way RM ANOVA performed on log transformed pain threshold and pain intensity data found significant effects for cycle (P ≤0.01) and cycle x group interaction (P ≤0.01). Further analysis found that Asian subjects produced a significantly greater increase in pain threshold and a significantly greater decrease in pain intensity rating during placebo TENS than White subjects. These findings suggest that ethnocultural background is an important determinant in placebo-induced analgesia in the laboratory setting. It is hoped that this preliminary study will serve to emphasize that ethnocultural factors should be considered during experiments utilizing human subjects.
Article
Objective. To provide an indication of the economic, social, and psychological impact of musculoskeletal conditions in the United States. Methods. Review of the literature combined with estimates of data concerning health care utilization and acute and chronic disability due to musculoskeletal conditions, from the 1990–1992 National Health Interview Survey. Results. The cost of musculoskeletal conditions was $149.4 billion in 1992, of which 48% was due to direct medical care costs and the remainder was due to indirect costs resulting from wage losses. This amount translates to ˜2.5% of the Gross National Product, a sharp rise since the prior studies, even if part of the increase is an artifact of improved accounting methods. Each year, persons with musculoskeletal conditions make 315 million physician visits, have more than 8 million hospital admissions, and experience ˜1.5 billion days of restricted activity. Approximately 42% of persons with musculoskeletal conditions–more than 17 million in all–are limited in their activities. Conclusion. The economic and social costs of musculoskeletal conditions are substantial. These conditions are responsible for a sizable amount of health care use and disability, and they significantly affect the psychological status of the individuals with the conditions as well as their families.
Article
Objective To determine the extent of motor dysfunction in people with knee osteoarthritis (OA), as compared with similarly aged subjects without knee OA, in a Chinese population.Methods Seventy-six subjects participated in this study. Isometric peak torque of the knee muscles, range of knee motion at rest and during walking, gait velocity, cadence, and stride length were compared.ResultsThe isometric peak torque of both the quadriceps and the hamstrings of the affected leg of patients with knee OA were weaker than those of the controls (most P < 0.05). The gait velocity was 23.4% slower (P = 0.001), the cadence 33.3% less (P < 0.001), and the stride length 13.4% shorter (P = 0.010) in the patients with OA. The range of knee motion in the patients was reduced by 11.2% at rest (P = 0.003) and by 14.7% during walking (P = 0.001).Conclusion Patients with knee OA exhibited statistically significant deficiencies in the physical performance tested, as compared with similarly aged subjects without knee OA (by 9.6% to 33.3%), in a Chinese population. The indication that this study group seems less severely limited than those reported in Western literature warrants further investigation. Arthritis Care Res 45:62–68, 2001. © 2001 by the American College of Rheumatology.
Article
This study investigated the immediate and possible cumulative effects respectively of a single 60 min of TENS and of 10 repeated daily applications on subjective pain sensation and flexion reflex. Twenty young healthy subjects were randomly assigned to a TENS or a placebo group, with 10 in each. TENS or placebo stimulation was applied to the lumbro-sacral region for 60 minutes on 10 treatment days over a two-week period. Before, during and after TENS and placebo stimulation on Day$ sb1$, Day$ sb5$ and Day$ sb{10}$, the FR was elicited by electrically stimulating the sole of subject's right foot and recorded electromyographically from biceps femoris (BF) and tibialis anterior (TA) muscles. Subjective pain sensation was measured using the visual analog scale (VAS). Compared to placebo stimulation, a single session of 60 min TENS significantly decreased the VAS scores (p $<$ 0.05) and TA FR areas (p $<$ 0.05) obtained during the 60 min post-stimulation period. However, the between-group difference in the decrease of the BF FR area did not reach statistical significance. After 10 repeated daily applications of TENS, the pre-stimulation VAS scores and FR areas of both muscles were significantly more inhibited (p $<$ 0.01) than placebo stimulation. Furthermore, the suppression of VAS scores during and after TENS was linearly correlated with that of FR areas of both muscles in each of the 3 testing days. These findings indicated that repeated daily TENS applications produced cumulative inhibitory influence on both subjective pain sensation and FR over a two-week period. Such a gradual development probably implicated that plastic changes could have been induced in the neural pathway. The similar time course of the inhibitory effects of TENS on the two pain indices, which could cumulate over time, suggest possible similar processing at both cortical (subjective pain) and spinal (FR) levels.
Article
The effect on the experimental tooth pain threshold of conditioning electrical stimulation via needles or surface electrodes applied to the hands and cheeks was studied in 34 dental students. Conditioning stimulation with 2/sec. gave a slowly increasing pain threshold followed by a slow return to the control level in the post-conditioning period. In each individual the amplitude of the threshold increase was reproduceable. It was concluded that these effects are not due to motivational but to more basic neurophysiological mechanisms. The pain threshold was increased mainly by segmental conditioning stimulation; segmentally unrelated stimulation gave usually only small effects. Conditioning stimulation with 100/sec. produced only a strict segmental short-lasting effect. Effects with characteristics of both 2/sec. and 100/sec. were obtained by conditioning at 10/sec. It is suggested that the transmission of impulses from the pain afferents to ascending pathways is controlled at the segmental level by (a) presynaptic inhibition within the group of afferents giving rise to the flexion reflex of which the pain afferents are assumed to be a part; (b) postsynaptic inhibition between alternate pathway excited by flexion reflex afferents; and (c) descending control from supraspinal systems which may utilize similar segmental mechanisms as the primary afferents.
Article
The analgesic effects induced by two different kinds of peripheral conditioning stimulations, electroacupuncture (EA) and transcutaneous electrical nerve stimulation (TENS), were compared in the rat using the latency of radiant heat-evoked tail flick reflex as nociceptive index. The parallel elevations of withdrawal latency of tail flick were produced by EA and TENS administrations at the acupoints of S36 and Sp6 with low intensity (1-2-3 mA) and one of three different frequencies (2, 15 and 100 Hz). Analgesic effects of EA or TENS were characterized by slow-on and slow-off nature, and a significant linear correlation was found between both at any one of three frequencies. Systemic naloxone hydrochloride (2 mg/kg) almost completely and partially antagonized 2 and 15 Hz EA- or TENS-induced analgesia, respectively, but failed to affect those induced by 100 Hz EA or TENS. Tolerance to EA stimulation with one of three frequencies reduced the corresponding frequency TENS-induced analgesia and vice versa. These data indicate that: (a) there is no significant difference in producing antinociception for two different peripheral conditioning stimulations when applied at the same sites and (b) the common neural mechanisms most likely process the analgesic effects of EA and TENS. The involvement of (an) endogenous opiate mechanism in the management of different frequency EA and TENS analgesia is discussed in detail.